Amphiphilic Fullerene-BODIPY Photosensitizers for Targeted Photodynamic Therapy

Area of Science:

• Nanomedicine
• Photodynamic Therapy
• Organic Chemistry

Background:

• Nanotheranostic carriers offer advantages over conventional agents in photodynamic therapy (PDT).
• Fullerene and BODIPY dyes are effective components for singlet oxygen generation.
• Targeted delivery systems are crucial for enhancing anti-cancer efficacy.

Purpose of the Study:

• To synthesize and characterize novel amphiphilic glucose-BODIPY-fullerene dyads for PDT.
• To investigate the formation of nanomicelles from these dyads for improved drug delivery.
• To evaluate the in vitro anti-tumor effects of the synthesized compounds and their nanomicelles.

Main Methods:

• Synthesis of four new heavy atom-free amphiphilic glucose-BODIPY-fullerene dyads (14-17).
• Formation of nanomicelles (14-17NM) using Tween 80.
• In vitro evaluation of anti-tumor activity using K562 human chronic myelogenous leukemia cells under light and dark conditions.
• Assessment of singlet oxygen and reactive oxygen species (ROS) generation.

Main Results:

• Successful synthesis of glucose-BODIPY-fullerene dyads and their corresponding nanomicelles.
• Efficient generation of singlet oxygen and ROS upon light irradiation.
• Demonstrated in vitro anti-tumor toxicity of the compounds and nanomicelles, particularly under light exposure.

Conclusions:

• The developed glucose-BODIPY-fullerene nanovehicles are effective platforms for PDT.
• The combination of fullerene as a spin converter and BODIPY as a light-harvesting unit enhances anti-cancer efficacy.
• These findings present a promising strategy for cancer treatment using targeted nanocarriers.